Prevalence of atrial fibrillation and related factors in hospitalized old patients: ESFINGE study;Prevalencia de la fibrilación auricular y factores relacionados en pacientes ancianos hospitalizados: estudio ESFINGE

Medicina Clinica

Volumn 138, Issue 6, 2012, Pages 231-237

  López Soto, Alfonso ^a   Formiga, Francesc ^b   Bosch, Xavier ^a   García Alegría, Javier ^c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c HOSPITAL COSTA DEL SOL   (Spain)

Author keywords

Antiarrhythmic drugs; Atrial fibrillation; Elderly; Heart failure

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT;

AGED; AGED HOSPITAL PATIENT; ANTICOAGULANT THERAPY; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; THROMBOEMBOLISM; UNSPECIFIED SIDE EFFECT;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; COMORBIDITY; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SPAIN;

EID: 84857791961     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2011.05.023     Document Type: Article

References (30)

1. A.S. Go, E.M. Hylek, K.A. Phillips, Y. Chang, L.E. Henault, and J.V. Selby Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study JAMA 285 2001 2370 2375 (Pubitemid 32424106)
2. P.A. Wolf, R.D. Abbott, and W.B. Kannel Atrial fibrillation as an independent risk factor for stroke: the Framingham Study Stroke 22 1991 983 988
3. T. Yamada, and G.N. Kay Catheter ablation of atrial fibrillation in the elderly Pacing Clin Electrophysiol 32 2009 1085 1091
4. V. Fuster, L.E. Rydén, D.S. Cannom, H.J. Crijns, A.B. Curtis, and K.A. Ellenbogen ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Circulation 114 2006 e257 e354
5. J.M. García Acuña, J.R. González Juanatey, E. Alegría, I. González, and J.L. Listerri La fibrilación auricular permanente en las enfermedades cardiovasculares en España. Estudio CARDIOTENS 1999 Rev Esp Cardiol 55 2002 943 952 (Pubitemid 35175170)
6. L. Cea Calvo, J. Redón, J.V. Lozano, C. Fernández- Pérez, J.C. Martí, J. Listerri en representación de los investigadores del estudio PREV-ICTUS Prevalencia de fibrilación auricular en la población española de 60 o más años de edad. Estudio PREV-ICTUS Rev Esp Cardiol 60 2007 616 624
7. A.J. Camm, P. Kirchhof, G.Y. Lip, U. Schotten, I. Savelieva, and S. Ernst European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Europace 12 2010 1360 1420
8. K. Lakshminarayan, C.A. Solid, A.J. Collins, D.C. Anderson, and C.A. Herzog Atrial fibrillation and stroke in the general medicare population: a 10-year perspective (1992 to 2002) Stroke 37 2006 1969 1974 (Pubitemid 44309888)
9. Atrial Fibrillation Investigators Risk factors for stroke and efcacy of antithrombotic therapy in atrial brillation: analysis of pooled data from ve randomized controlled trials Arch Intern Med 154 1994 1449 1457
10. B.A. Van Deelen, P.M. van den Bemt, T.C. Egberts, A. van't Hoff, and H.A. Maas Cognitive impairment as determinant for sub-optimal control of oral anticoagulation treatment in elderly patients with atrial fibrillation Drugs Aging 22 2005 353 360 (Pubitemid 40656023)
11. D.P. Schauer, C.J. Moomaw, M. Wess, T. Webb, and M.H. Eckman Psychosocial risk factors for adverse outcomes in patients with nonvalvular atrial fibrillation receiving warfarin J Gen Intern Med 20 2005 1114 1119 (Pubitemid 43110261)
12. C.L. Lackie, K.A. Garbarino, and J.A. Pruetz Warfarin therapy for atrial fibrillation in the elderly Ann Pharmacother 36 2002 200 204 (Pubitemid 34126807)
13. G. Palareti, C. Legnani, G. Guazzaloca, V. Lelia, B. Cosmi, and B. Lunghi Risks factors for highly unstable response to oral anticoagulation: a case-control study Br J Haematol 129 2005 72 78 (Pubitemid 40524054)
14. E.M. Hylek, J. D'Antonio, C. Evans-Molina, C. Shea, L.E. Henault, and S. Regan Translating the results of randomized trials into clinical practice: the challenge of warfarin candidacy among hospitalized elderly patients with atrial fibrillation Stroke 37 2006 1075 1080
15. F.L. Mahoney, and D.W. Barthel Functional evaluation: the Barthel Index Md State Med J 14 1965 61 65
16. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373 383 (Pubitemid 17055592)
17. S. Stewart, C.L. Hart, D.J. Hole, and J.J. McMurray A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study Am J Med 113 2002 359 364 (Pubitemid 35223606)
18. W.B. Kannel, R.D. Abbott, D.D. Savage, and P.M. McNamara Epidemiologic features of chronic atrial fibrillation: the Framingham study N Engl J Med 306 1982 1018 1022 (Pubitemid 12155370)
19. S.S. Rathore, A.K. Berger, K.P. Weinfurt, K.A. Schulman, W.J. Oetgen, and B.J. Gersh Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes Circulation 101 2000 969 974 (Pubitemid 30131697)
20. W.S. Aronow Management of the older person with atrial fibrillation J Gerontol A Biol Sci Med Sci 57 2002 M352 M363
21. E.N. Prystowsky Assessment of rhythm and rate control in patients with atrial fibrillation J Cardiovasc Electrophysiol 17 Suppl 2 2006 S7 S10
22. J.L. Hurwitz Atrial fibrillation treatment in the elderly: are we getting closer to an answer? J Cardiovasc Electrophysiol 19 2008 812 814 (Pubitemid 352032792)
23. E.J. Benjamin, D. Levy, S.M. Vaziri, R.B. D'Agostino, A.J. Belanger, and P.A. Wolf Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study JAMA 271 1994 840 844
24. E. Martín-Rioboó, E. García Criado, L.A. Pérula de Torres, L. Cea-Calvo, M. Anguita Sánchez, and A. López Granados Prevalence of left ventricular hypertrophy, atrial fibrillation and cardiovascular disease in hypertensive patients of Andalusia, Spain. PREHVIA study Med Clin (Barc) 132 2009 243 250
25. T.D. Vagaonescu, A.C. Wilson, and J.B. Kostis Atrial fibrillation and isolated systolic hypertension: the systolic hypertension in the elderly program and systolic hypertension in the elderly program-extension study Hypertension 51 2008 1552 1556
26. M.C. Fang Antithrombotic therapy for the treatment of atrial fibrillation in the elderly J Interv Card Electrophysiol 25 2009 19 23
27. E. Birman-Deych, M.J. Radford, D.S. Nilasena, and B.F. Gage Use and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillation Stroke 37 2006 1070 1074
28. A.S. Go, E.M. Hylek, Y. Chang, K.A. Phillips, L.E. Henault, and A.M. Capra Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA 290 2003 2685 2692 (Pubitemid 37475596)
29. Y. Guo, Q. Wu, L. Zhang, T. Yang, P. Zhu, and W. Gao Antithrombotic therapy in very elderly patients with atrial fibrillation: is it enough to assess thromboembolic risk? Clin Interv Aging 5 2010 157 162
30. J.M. Alegret, X. Viñolas, J. Villacastín, J.G. Martínez, N. Pachón, and F. Crespo Use and clinical implications of anticoagulation maintenance after a successful cardioversion Med Clin (Barc) 137 2011 14 16